US4977081A
(en)
|
1987-05-04 |
1990-12-11 |
Adi Diagnostics, Inc. |
Stable rabbit-mouse hybridomas and secretion products thereof
|
JP3095168B2
(en)
|
1988-02-05 |
2000-10-03 |
エル. モリソン,シェリー |
Antibodies with domain-denaturing constants
|
DE68929167T2
(en)
|
1988-09-06 |
2000-11-16 |
Xoma Corp |
Gene expression elements and production of chimeric mouse-human antibodies
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
US5574205A
(en)
|
1989-07-25 |
1996-11-12 |
Cell Genesys |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
ES2090299T3
(en)
|
1989-12-01 |
1996-10-16 |
Pharming Bv |
PRODUCTION OF RECOMBINANT POLYPEPTIDES THROUGH BOVINE SPECIES AND TRANSGENIC METHODS.
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
AU633698B2
(en)
|
1990-01-12 |
1993-02-04 |
Amgen Fremont Inc. |
Generation of xenogeneic antibodies
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
EP0491057B1
(en)
|
1990-07-10 |
1998-12-30 |
Nkk Corporation |
Hybridoma which produces avian specific immunoglobulin g
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
CA2078539C
(en)
|
1991-09-18 |
2005-08-02 |
Kenya Shitara |
Process for producing humanized chimera antibody
|
US7067284B1
(en)
|
1992-01-27 |
2006-06-27 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
AU668423B2
(en)
|
1992-08-17 |
1996-05-02 |
Genentech Inc. |
Bispecific immunoadhesins
|
EP0583980A1
(en)
|
1992-08-20 |
1994-02-23 |
Eli Lilly And Company |
Method for generating monoclonal antibodies from rabbits
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
DK0656946T4
(en)
|
1992-08-21 |
2010-07-26 |
Univ Bruxelles |
Immunoglobulins without light chains
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
EP0671951A4
(en)
|
1992-12-01 |
1997-05-21 |
Protein Design Labs Inc |
Humanized antibodies reactive with l-selectin.
|
EP0754225A4
(en)
|
1993-04-26 |
2001-01-31 |
Genpharm Int |
Transgenic non-human animals capable of producing heterologous antibodies
|
AU6796094A
(en)
|
1993-04-29 |
1994-11-21 |
Raymond Hamers |
Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of (camelidae)
|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
WO1995017500A1
(en)
|
1993-12-23 |
1995-06-29 |
Abs Global, Inc. |
Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
|
WO1995020401A1
(en)
|
1994-01-31 |
1995-08-03 |
Trustees Of Boston University |
Polyclonal antibody libraries
|
US7119248B1
(en)
|
1994-04-12 |
2006-10-10 |
Miltenyi Biotec Gmbh |
Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
|
US6080560A
(en)
|
1994-07-25 |
2000-06-27 |
Monsanto Company |
Method for producing antibodies in plant cells
|
US6111166A
(en)
*
|
1994-09-19 |
2000-08-29 |
Medarex, Incorporated |
Transgenic mice expressing human Fcα and β receptors
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
US6632976B1
(en)
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
AU7326796A
(en)
|
1995-10-30 |
1997-05-22 |
Spectral Diagnostics Inc. |
Stable chicken b-cell line and method of use thereof
|
US5716081A
(en)
|
1996-03-11 |
1998-02-10 |
Automotive Products (Usa), Inc. |
Spring clip for quick connect coupling
|
AU3507297A
(en)
|
1996-06-26 |
1998-01-14 |
Baylor College Of Medicine |
Chromosomal rearrangement by insertion of two recombination substrates
|
ES2176574T3
(en)
|
1996-09-03 |
2002-12-01 |
Gsf Forschungszentrum Umwelt |
USE OF BI AND TRIESPECIFIC ANTIBODIES FOR INDUCTION OF TUMOR IMMUNITY.
|
CA2616914C
(en)
|
1996-12-03 |
2012-05-29 |
Abgenix, Inc. |
Egfr-binding antibody
|
US6080910A
(en)
|
1997-02-20 |
2000-06-27 |
Case Western Reserve University |
Transgenic knockout animals lacking IgG3
|
NZ337495A
(en)
|
1997-03-06 |
2001-06-29 |
Infigen Inc |
Bovine primordial germ cells and their use in cloning
|
CN1203922A
(en)
|
1997-03-21 |
1999-01-06 |
三共株式会社 |
Humanized anti-human fas antibody
|
CZ294425B6
(en)
|
1997-04-14 |
2005-01-12 |
Micromet Ag |
Process for preparing anti-human antigen receptor, anti-human antigen receptor per se, VH and VL chain, kit for the selection of anti-human antigen receptors and pharmaceutical composition containing such a receptor
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
ES2246069T3
(en)
|
1997-05-02 |
2006-02-01 |
Genentech, Inc. |
PROCEDURE FOR THE PREPARATION OF MULTI-SPECIFIC ANTIBODIES THAT HAVE COMMON AND MULTIMERIC COMPONENTS.
|
US6774279B2
(en)
|
1997-05-30 |
2004-08-10 |
Carnegie Institution Of Washington |
Use of FLP recombinase in mice
|
CA2305712A1
(en)
|
1997-10-03 |
1999-04-15 |
Chugai Seiyaku Kabushiki Kaisha |
Natural humanized antibody
|
DK1034262T3
(en)
|
1997-11-18 |
2005-11-28 |
Pioneer Hi Bred Int |
Compositions and Methods for Genetic Modification of Plants
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
SI1533380T1
(en)
|
1999-04-15 |
2010-03-31 |
Crucell Holland Bv |
Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
|
CA2373638A1
(en)
|
1999-05-27 |
2000-12-07 |
Human Genome Sciences, Inc. |
Adam polynucleotides and polypeptides
|
GB0001448D0
(en)
|
2000-01-21 |
2000-03-08 |
Novartis Ag |
Organic compounds
|
CA2401965A1
(en)
|
2000-02-29 |
2001-09-07 |
Auburn University |
Production of antibodies in transgenic plastids
|
CN101498731A
(en)
|
2000-05-18 |
2009-08-05 |
日本烟草产业株式会社 |
Human monoclonal antibody against a costimulatory signal transduction molecule ATLIM and pharmaceutical use thereof
|
CN1455817A
(en)
|
2000-07-21 |
2003-11-12 |
(由农业部部长代表的)美利坚合众国 |
Methods for replacement, translocation and stacking of DNA in eukaryotic genomes
|
NZ524523A
(en)
|
2000-08-03 |
2006-02-24 |
Therapeutic Human Polyclonals |
Production of humanized antibodies in transgenic animals
|
EP1184458A1
(en)
|
2000-08-28 |
2002-03-06 |
U-BISys B.V. |
Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof
|
US20020119148A1
(en)
|
2000-09-01 |
2002-08-29 |
Gerritsen Mary E. |
ErbB4 antagonists
|
WO2002020767A2
(en)
|
2000-09-08 |
2002-03-14 |
Massachusetts Institute Of Technology |
G-csf analog compositions and methods
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
DZ3494A1
(en)
|
2001-01-05 |
2002-07-11 |
Pfizer |
INSULIN ANALOGUE GROWTH FACTOR ANTI-RECEPTOR ANTIBODIES
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US6961875B2
(en)
|
2001-03-22 |
2005-11-01 |
International Business Machines Corporation |
Method and apparatus for capturing event traces for debug and analysis
|
GB0110029D0
(en)
|
2001-04-24 |
2001-06-13 |
Grosveld Frank |
Transgenic animal
|
US7034134B2
(en)
|
2001-04-26 |
2006-04-25 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
|
US7476536B2
(en)
|
2001-05-11 |
2009-01-13 |
Kirin Pharma Kabushiki Kaisha |
Artificial human chromosome containing human antibody a light chain gene
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
EP1399484B1
(en)
|
2001-06-28 |
2010-08-11 |
Domantis Limited |
Dual-specific ligand and its use
|
EP1539233B1
(en)
|
2001-07-12 |
2011-04-27 |
FOOTE, Jefferson |
Super humanized antibodies
|
FR2827302B1
(en)
|
2001-07-13 |
2003-10-10 |
Genoway |
TRANSGENIC CELL AND ANIMAL MODELING HUMAN ANTIGENIC PRESENTATION AND USES THEREOF
|
CA2898314A1
(en)
|
2001-07-19 |
2003-07-31 |
Perian Therapeutics, Inc. |
Multimeric proteins and methods of making and using same
|
ES2350248T3
(en)
|
2001-10-01 |
2011-01-20 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
PROCEDURE FOR THE PRODUCTION OF PROTEIN LIBRARIES AND THE SELECTION OF PROTEINS FROM THE SAME.
|
WO2003031656A1
(en)
|
2001-10-05 |
2003-04-17 |
United States Environmental Protection Agency |
Genetic testing for male factor infertility
|
US20060199204A1
(en)
|
2001-10-05 |
2006-09-07 |
U.S. Epa |
Genetic testing for male factor infertility
|
US7435871B2
(en)
|
2001-11-30 |
2008-10-14 |
Amgen Fremont Inc. |
Transgenic animals bearing human Igλ light chain genes
|
DE60226641D1
(en)
|
2001-12-03 |
2008-06-26 |
Amgen Fremont Inc |
ANTIBODY CATEGORIZATION BASED ON BINDING CHARACTERISTICS
|
GB0130267D0
(en)
|
2001-12-19 |
2002-02-06 |
Neutec Pharma Plc |
Focussed antibody technology
|
AU2003214842A1
(en)
|
2002-01-17 |
2003-09-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Mutations caused by activation-induced cytidine deaminase
|
JP2005527490A
(en)
|
2002-01-18 |
2005-09-15 |
イノヴィオ アーエス |
Bispecific antibody DNA constructs for intramuscular administration
|
AU2003230741A1
(en)
|
2002-03-22 |
2003-10-13 |
Origen Therapeutics |
Transgenic aves producing human polyclonal antibodies
|
US7732149B2
(en)
|
2002-04-26 |
2010-06-08 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of screening agonistic antibodies
|
MXPA04012656A
(en)
|
2002-06-14 |
2005-08-15 |
Immunomedics Inc |
Humanized monoclonal antiboby hpam4.
|
EP1575499A2
(en)
|
2002-06-28 |
2005-09-21 |
Centocor, Inc. |
Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
|
ATE328906T1
(en)
|
2002-06-28 |
2006-06-15 |
Domantis Ltd |
DUAL-SPECIFIC LIGANDS WITH INCREASED HALF-LIFE
|
CN101962408A
(en)
|
2002-07-12 |
2011-02-02 |
杰斐逊·富特 |
Super-humanized antibody
|
CA2872136C
(en)
|
2002-07-18 |
2017-06-20 |
Merus B.V. |
Recombinant production of mixtures of antibodies
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
CL2003002461A1
(en)
|
2002-11-27 |
2005-01-07 |
Dow Chemical Company Agroscien |
IMMUNOGLOBULIN THAT UNDERSTANDS AT LEAST ONE AFUCOSILATED GLICAN, COMPOSITION THAT CONTAINS IT, NUCLEOTIDIC SEQUENCE AND VECTOR THAT UNDERSTANDS IT, PROCEDURE TO PRODUCE IMMUNOGLOBULIN SAID IN PLANTS.
|
GB0228210D0
(en)
|
2002-12-03 |
2003-01-08 |
Babraham Inst |
Single chain antibodies
|
EP1578801A2
(en)
|
2002-12-27 |
2005-09-28 |
Domantis Limited |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
GB0230201D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Retargeting
|
GB0230203D0
(en)
*
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
EP1439234A1
(en)
|
2003-01-08 |
2004-07-21 |
ARTEMIS Pharmaceuticals GmbH |
Targeted transgenesis using the rosa26 locus
|
DE602004021095D1
(en)
|
2003-01-21 |
2009-06-25 |
Chugai Pharmaceutical Co Ltd |
METHOD OF SCREENING THE LIGHT CHAIN OF AN ANTIBODY
|
JP4966006B2
(en)
|
2003-01-28 |
2012-07-04 |
セレクティス |
Custom-made meganucleases and their use
|
GB2398784B
(en)
|
2003-02-26 |
2005-07-27 |
Babraham Inst |
Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
|
CA2517519A1
(en)
|
2003-03-04 |
2004-09-16 |
Alexion Pharmaceuticals, Inc. |
Vectors used to create hybrid constant regions
|
CA2527694C
(en)
|
2003-05-30 |
2015-07-14 |
Hendricus Renerus Jacobus Mattheus Hoogenboom |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
WO2005001087A2
(en)
|
2003-06-11 |
2005-01-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying genes in eukaryotic cells
|
WO2005007696A2
(en)
|
2003-07-15 |
2005-01-27 |
Therapeutic Human Polyclonals, Inc. |
Humanized immunoglobulin loci
|
US20050153392A1
(en)
|
2003-08-11 |
2005-07-14 |
Roland Buelow |
Transgenesis with humanized immunoglobulin loci
|
RU2251699C1
(en)
|
2003-09-25 |
2005-05-10 |
Киселев Всеволод Иванович |
Method for early and preclinical diagnostics of cervical cancer
|
WO2005038001A2
(en)
|
2003-10-14 |
2005-04-28 |
Therapeutic Human Polyclonals, Inc. |
Improved transgenesis by sperm-mediated gene transfer
|
FR2861255B1
(en)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
NON-HUMAN TRANSGENIC MAMMAL FOR THE CONSTANT REGION OF THE HEAVY CHAIN OF HUMAN CLASS A IMMUNOGLOBULINS AND ITS APPLICATIONS
|
CA2550551C
(en)
|
2004-01-16 |
2013-10-29 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
CN1560081A
(en)
|
2004-02-17 |
2005-01-05 |
大连帝恩生物工程有限公司 |
Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof
|
US7625549B2
(en)
|
2004-03-19 |
2009-12-01 |
Amgen Fremont Inc. |
Determining the risk of human anti-human antibodies in transgenic mice
|
KR101443473B1
(en)
|
2004-07-22 |
2014-09-22 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
A method for the isolation of vh binding domains
|
WO2006039418A2
(en)
*
|
2004-09-30 |
2006-04-13 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor ii (cd32)
|
DK2767161T3
(en)
|
2004-10-19 |
2018-05-07 |
Regeneron Pharma |
Method of generating an animal homozygous for genetic modification
|
WO2006047367A2
(en)
|
2004-10-22 |
2006-05-04 |
Therapeutic Human Polyclonals, Inc. |
Suppression of endogenous immunoglubolin expression in non-human transgenic animals
|
KR20070090890A
(en)
|
2004-10-22 |
2007-09-06 |
메디뮨 인코포레이티드 |
High affinity antibodies against hmgb1 and methods of use thereof
|
JP2008538912A
(en)
|
2005-04-29 |
2008-11-13 |
イナート・ファルマ |
Transgenic animal and method for producing recombinant antibody
|
CA2608481A1
(en)
|
2005-05-14 |
2006-11-23 |
Fudan University |
Piggybac as a tool for genetic manipulation and analysis in vertebrates
|
FR2888850B1
(en)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
NOVEL ANTI-IGF-IR ANTIBODIES AND THEIR APPLICATIONS
|
EP1973576B1
(en)
|
2005-11-28 |
2019-05-15 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
JP2009518320A
(en)
|
2005-12-05 |
2009-05-07 |
シュムフォウエン アクティーゼルスカブ |
Anti-orthopox virus recombinant polyclonal antibody
|
GB0618345D0
(en)
|
2006-09-18 |
2006-10-25 |
Univ Erasmus |
Binding molecules
|
TWI404727B
(en)
|
2006-01-25 |
2013-08-11 |
Univ Erasmus Medical Ct |
Allelic exclusion
|
US7462759B2
(en)
|
2006-02-03 |
2008-12-09 |
Pioneer Hi-Bred International, Inc. |
Brittle stalk 2 gene family and related methods and uses
|
DE602007009954D1
(en)
|
2006-03-22 |
2010-12-02 |
Viral Logic Systems Technology |
METHOD FOR IDENTIFYING POLYPEPTIDE TARGETS
|
WO2007117410A2
(en)
|
2006-03-31 |
2007-10-18 |
Medarex, Inc. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
MX2008014804A
(en)
|
2006-06-02 |
2009-01-27 |
Regeneron Pharma |
High affinity antibodies to human il-6 receptor.
|
WO2008022391A1
(en)
|
2006-08-22 |
2008-02-28 |
G2 Inflammation Pty Ltd |
Method for producing antibodies
|
PE20081216A1
(en)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
ENHANCED EXPRESSION OF HUMAN OR HUMANIZED IMMUNOGLOBULIN IN NON-HUMAN TRANSGENIC ANIMALS
|
CN101522716B
(en)
|
2006-10-02 |
2013-03-20 |
瑞泽恩制药公司 |
High affinity human antibodies to human IL-4 receptor
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
RU2448979C2
(en)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Human antibodies to delta-like human ligand-4
|
GB0700194D0
(en)
|
2007-01-05 |
2007-02-14 |
Univ Edinburgh |
Humanisation of animals
|
KR20090130236A
(en)
|
2007-03-13 |
2009-12-21 |
내셔날 쥬이쉬 헬스 |
Methods for generation of antibodies
|
GB0706628D0
(en)
|
2007-04-04 |
2007-05-16 |
Univ Erasmus |
Germ-line manipulation 1
|
CN101784664B
(en)
|
2007-06-01 |
2013-04-10 |
Omt公司 |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
|
JP2010528664A
(en)
|
2007-06-08 |
2010-08-26 |
ダウ グローバル テクノロジーズ インコーポレイティド |
Expression of soluble antibody fragments by cleavage of the CH1 domain
|
WO2009013620A2
(en)
*
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
ITMI20071522A1
(en)
|
2007-07-27 |
2009-01-28 |
Areta Internat S R L |
IDIOTYPIC VACCINE
|
WO2009018386A1
(en)
|
2007-07-31 |
2009-02-05 |
Medimmune, Llc |
Multispecific epitope binding proteins and uses thereof
|
EP2185692A4
(en)
|
2007-08-10 |
2012-05-02 |
Medarex Inc |
Hco32 and hco27 and related examples
|
JP2010536341A
(en)
|
2007-08-15 |
2010-12-02 |
アムニクス, インコーポレイテッド |
Compositions and methods for altering properties of biologically active polypeptides
|
NO2195023T3
(en)
*
|
2007-08-29 |
2018-08-04 |
|
|
US8426565B2
(en)
|
2007-08-30 |
2013-04-23 |
Walter And Eliza Hall Institute Of Medical Research |
Dendritic cell marker and uses thereof
|
CA2697193C
(en)
|
2007-09-14 |
2017-06-06 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
PH12018501459A1
(en)
|
2007-09-26 |
2019-11-11 |
Chugai Pharmaceutical Co Ltd |
Modified antibody constant region
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
WO2009051974A1
(en)
|
2007-10-17 |
2009-04-23 |
Nuvelo, Inc. |
Antibodes to cll-1
|
ES2483942T5
(en)
|
2007-12-14 |
2017-02-06 |
Novo Nordisk A/S |
Antibodies against human NKG2D and their uses
|
SI2235064T1
(en)
|
2008-01-07 |
2016-04-29 |
Amgen Inc. |
Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
|
EP2271758B1
(en)
|
2008-04-14 |
2018-09-12 |
Innovative Targeting Solutions Inc. |
Sequence diversity generation in immunoglobulins
|
KR20110020860A
(en)
*
|
2008-05-23 |
2011-03-03 |
알리바 바이오파마수티컬스, 아이엔씨. |
Method of generating single vl domain antibodies in transgenic animals
|
US20100122358A1
(en)
*
|
2008-06-06 |
2010-05-13 |
Crescendo Biologics Limited |
H-Chain-only antibodies
|
AU2009263082C1
(en)
|
2008-06-27 |
2018-11-01 |
Merus N.V. |
Antibody producing non-human mammals
|
AU2009298458B2
(en)
|
2008-09-30 |
2015-10-08 |
Ablexis, Llc |
Non-human mammals for the production of chimeric antibodies
|
DK2356270T3
(en)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
AU2009329365B2
(en)
|
2008-12-18 |
2016-01-14 |
Roger Kingdon Craig |
Non-human transgenic animals expressing humanised antibodies and use thereof
|
WO2010091182A2
(en)
|
2009-02-04 |
2010-08-12 |
Molecular Innovations |
Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
|
CA2753287A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
AU2010233995A1
(en)
|
2009-04-07 |
2011-09-08 |
Roche Glycart Ag |
Bispecific anti-ErbB-2/anti-c-Met antibodies
|
JP5647222B2
(en)
*
|
2009-04-10 |
2014-12-24 |
アブリンクス エン.ヴェー. |
Improved amino acid sequence directed against IL-6R for the treatment of IL-6R related diseases and disorders and polypeptides comprising the same
|
JP5804521B2
(en)
|
2009-05-29 |
2015-11-04 |
モルフォシス・アー・ゲー |
Collection and its usage
|
CN102471378B
(en)
|
2009-06-26 |
2014-04-02 |
瑞泽恩制药公司 |
Readily isolated bispecific antibodies with native immuneoglobulin format
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
US20120204278A1
(en)
|
2009-07-08 |
2012-08-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
HUE055817T2
(en)
|
2009-07-08 |
2021-12-28 |
Kymab Ltd |
Animal models and therapeutic molecules
|
JP5796846B2
(en)
|
2009-11-17 |
2015-10-21 |
エスエービー エルエルシー |
Human artificial chromosome vector
|
LT2954779T
(en)
|
2009-12-10 |
2019-05-27 |
Regeneron Pharmaceuticals, Inc. |
Mice that make heavy chain antibodies
|
SG181690A1
(en)
*
|
2009-12-21 |
2012-07-30 |
Regeneron Pharma |
Humanized fcy r mice
|
US20120021409A1
(en)
*
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
SI3095871T1
(en)
*
|
2010-02-08 |
2019-06-28 |
Regeneron Pharmaceuticals, Inc. |
Common light chain mouse
|
US20130185821A1
(en)
|
2010-02-08 |
2013-07-18 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
EP2569337A1
(en)
|
2010-05-14 |
2013-03-20 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
CN103228130B
(en)
|
2010-06-17 |
2016-03-16 |
科马布有限公司 |
Animal model and treatment molecule
|
IL300712A
(en)
|
2010-06-22 |
2023-04-01 |
Regeneron Pharma |
Human lambda light chain mice
|
DK2601298T3
(en)
|
2010-08-02 |
2017-02-27 |
Regeneron Pharma |
Mice generating binding proteins comprising VL domains
|
EP2638155A1
(en)
|
2010-11-08 |
2013-09-18 |
Kymab Limited |
Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
|
PL2550363T3
(en)
|
2011-02-25 |
2015-05-29 |
Regeneron Pharma |
Adam6 mice
|
CA2824824A1
(en)
|
2011-02-28 |
2012-09-07 |
F. Hoffmann-La Roche Ag |
Monovalent antigen binding proteins
|
MX341921B
(en)
|
2011-02-28 |
2016-09-07 |
Hoffmann La Roche |
Antigen binding proteins.
|
RS61946B1
(en)
|
2011-08-05 |
2021-07-30 |
Regeneron Pharma |
Humanized universal light chain mice
|
WO2013041845A2
(en)
|
2011-09-19 |
2013-03-28 |
Kymab Limited |
Animals, repertoires & methods
|
CA2846319A1
(en)
|
2011-09-19 |
2013-03-28 |
Kymab Limited |
Antibodies, variable domains & chains tailored for human use
|
WO2013045916A1
(en)
|
2011-09-26 |
2013-04-04 |
Kymab Limited |
Chimaeric surrogate light chains (slc) comprising human vpreb
|
CA2791109C
(en)
|
2011-09-26 |
2021-02-16 |
Merus B.V. |
Generation of binding molecules
|
EP3216871B1
(en)
|
2011-10-17 |
2021-12-22 |
Regeneron Pharmaceuticals, Inc. |
Restricted immunoglobulin heavy chain mice
|
GB2496375A
(en)
|
2011-10-28 |
2013-05-15 |
Kymab Ltd |
A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
PT2793567T
(en)
|
2011-12-20 |
2019-05-27 |
Regeneron Pharma |
Humanized light chain mice
|
ES2753774T3
(en)
|
2012-02-01 |
2020-04-14 |
Regeneron Pharma |
Humanized mice expressing heavy chains containing VL domains
|
KR20140136462A
(en)
|
2012-03-06 |
2014-11-28 |
리제너론 파마슈티칼스 인코포레이티드 |
Common light chain mouse
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
ES2743399T3
(en)
|
2012-04-20 |
2020-02-19 |
Merus Nv |
Methods and means for the production of Ig-like heterodimeric molecules
|
TWI682941B
(en)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
Antibodies comprising chimeric constant domains
|
KR20150126863A
(en)
|
2013-03-13 |
2015-11-13 |
리제너론 파마슈티칼스 인코포레이티드 |
Common light chain mouse
|
PT2967013T
(en)
|
2013-03-13 |
2019-04-03 |
Regeneron Pharma |
Mice expressing a limited immunoglobulin light chain repertoire
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
JP6411463B2
(en)
|
2013-04-16 |
2018-10-24 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Targeted modification of rat genome
|
US10881085B2
(en)
*
|
2014-03-21 |
2021-01-05 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that make single domain binding proteins
|
SG10201808083VA
(en)
|
2014-03-21 |
2018-10-30 |
Regeneron Pharma |
Vl antigen binding proteins exhibiting distinct binding characteristics
|
EP3271403A1
(en)
|
2015-03-19 |
2018-01-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|